U.S. Markets closed

Concert Pharmaceuticals, Inc. (CNCE)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
3.5200-0.1000 (-2.76%)
At close: 4:00PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) 0.49
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 313.5000
52 Week Low 33.1200
50-Day Moving Average 33.4709
200-Day Moving Average 34.1083

Share Statistics

Avg Vol (3 month) 3182.64k
Avg Vol (10 day) 385.08k
Shares Outstanding 532.17M
Implied Shares Outstanding 6N/A
Float 823.86M
% Held by Insiders 19.72%
% Held by Institutions 166.30%
Shares Short (May 27, 2021) 41.49M
Short Ratio (May 27, 2021) 45.96
Short % of Float (May 27, 2021) 45.20%
Short % of Shares Outstanding (May 27, 2021) 44.63%
Shares Short (prior month Apr 29, 2021) 41.32M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Mar 30, 2021

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-987.04%

Management Effectiveness

Return on Assets (ttm)-29.78%
Return on Equity (ttm)-57.32%

Income Statement

Revenue (ttm)7.9M
Revenue Per Share (ttm)0.24
Quarterly Revenue Growth (yoy)-28.60%
Gross Profit (ttm)-53.72M
EBITDA -76.39M
Net Income Avi to Common (ttm)-76.96M
Diluted EPS (ttm)-2.3760
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)115.04M
Total Cash Per Share (mrq)3.58
Total Debt (mrq)15.78M
Total Debt/Equity (mrq)13.83
Current Ratio (mrq)14.92
Book Value Per Share (mrq)3.54

Cash Flow Statement

Operating Cash Flow (ttm)-71.92M
Levered Free Cash Flow (ttm)-43.44M